KR20200132142A - 개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물 - Google Patents

개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물 Download PDF

Info

Publication number: KR20200132142A
Authority: KR; South Korea
Prior art keywords: composition; microparticles; meth; acrylate; less
Prior art date: 2019-05-15

Application number

KR1020190057114A

Other languages

English (en)

Korean (ko)

Inventor

임형준

박정은

박성일

서병휘

Original Assignee

(주)아모레퍼시픽

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-05-15

Filing date

2019-05-15

Publication date

2020-11-25

2019-05-15 Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽

2019-05-15 Priority to KR1020190057114A priority Critical patent/KR20200132142A/ko

2020-04-23 Priority to SG11202110332WA priority patent/SG11202110332WA/en

2020-04-23 Priority to PCT/KR2020/005395 priority patent/WO2020231036A1/ko

2020-05-06 Priority to TW109114991A priority patent/TW202108116A/zh

2020-11-25 Publication of KR20200132142A publication Critical patent/KR20200132142A/ko

Links

239000000203 mixture Substances 0.000 title claims abstract description 93
210000002374 sebum Anatomy 0.000 title claims abstract description 30
239000002537 cosmetic Substances 0.000 title claims abstract description 27
239000000516 sunscreening agent Substances 0.000 title claims description 13
230000000475 sunscreen effect Effects 0.000 title claims description 11
239000011859 microparticle Substances 0.000 claims abstract description 66
238000010521 absorption reaction Methods 0.000 claims abstract description 38
XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims abstract description 36
239000011159 matrix material Substances 0.000 claims abstract description 10
229920000642 polymer Polymers 0.000 claims abstract description 10
239000000428 dust Substances 0.000 claims description 21
239000000178 monomer Substances 0.000 claims description 17
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
239000003431 cross linking reagent Substances 0.000 claims description 9
238000000034 method Methods 0.000 claims description 6
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical group C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 4
XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 claims description 4
DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 4
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 4
STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 4
238000001179 sorption measurement Methods 0.000 claims description 4
229920002554 vinyl polymer Polymers 0.000 claims description 4
VDYWHVQKENANGY-UHFFFAOYSA-N 1,3-Butyleneglycol dimethacrylate Chemical compound CC(=C)C(=O)OC(C)CCOC(=O)C(C)=C VDYWHVQKENANGY-UHFFFAOYSA-N 0.000 claims description 2
HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 claims description 2
SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 claims description 2
KBKNKFIRGXQLDB-UHFFFAOYSA-N 2-fluoroethenylbenzene Chemical compound FC=CC1=CC=CC=C1 KBKNKFIRGXQLDB-UHFFFAOYSA-N 0.000 claims description 2
JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 claims description 2
SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 claims description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 claims description 2
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 claims description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 claims description 2
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
230000006750 UV protection Effects 0.000 abstract description 2
238000012360 testing method Methods 0.000 description 31
239000003921 oil Substances 0.000 description 30
230000000052 comparative effect Effects 0.000 description 24
239000000843 powder Substances 0.000 description 18
239000002245 particle Substances 0.000 description 13
239000004205 dimethyl polysiloxane Substances 0.000 description 12
235000013870 dimethyl polysiloxane Nutrition 0.000 description 12
238000009472 formulation Methods 0.000 description 12
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 12
239000002202 Polyethylene glycol Substances 0.000 description 11
230000000903 blocking effect Effects 0.000 description 11
229940008099 dimethicone Drugs 0.000 description 11
229920001223 polyethylene glycol Polymers 0.000 description 11
239000012071 phase Substances 0.000 description 10
229920003229 poly(methyl methacrylate) Polymers 0.000 description 9
239000004926 polymethyl methacrylate Substances 0.000 description 9
229920001296 polysiloxane Polymers 0.000 description 8
238000011156 evaluation Methods 0.000 description 7
239000004615 ingredient Substances 0.000 description 7
XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 6
230000035515 penetration Effects 0.000 description 6
239000012798 spherical particle Substances 0.000 description 6
238000005507 spraying Methods 0.000 description 6
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
-1 ester compounds Chemical class 0.000 description 5
238000005259 measurement Methods 0.000 description 5
229920002545 silicone oil Polymers 0.000 description 5
239000004094 surface-active agent Substances 0.000 description 5
239000003981 vehicle Substances 0.000 description 5
239000008346 aqueous phase Substances 0.000 description 4
238000004132 cross linking Methods 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000003995 emulsifying agent Substances 0.000 description 4
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
239000006071 cream Substances 0.000 description 3
DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 3
238000005096 rolling process Methods 0.000 description 3
235000010215 titanium dioxide Nutrition 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
206010015150 Erythema Diseases 0.000 description 2
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
239000002270 dispersing agent Substances 0.000 description 2
238000012674 dispersion polymerization Methods 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
231100000321 erythema Toxicity 0.000 description 2
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000006260 foam Substances 0.000 description 2
208000014674 injury Diseases 0.000 description 2
239000006210 lotion Substances 0.000 description 2
229960001679 octinoxate Drugs 0.000 description 2
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
229920001451 polypropylene glycol Polymers 0.000 description 2
239000002994 raw material Substances 0.000 description 2
229940057429 sorbitan isostearate Drugs 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000012549 training Methods 0.000 description 2
230000008733 trauma Effects 0.000 description 2
HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
206010003645 Atopy Diseases 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
206010016322 Feeling abnormal Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
208000022535 Infectious Skin disease Diseases 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
ADANNTOYRVPQLJ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ADANNTOYRVPQLJ-UHFFFAOYSA-N 0.000 description 1
150000001252 acrylic acid derivatives Chemical class 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
229960005193 avobenzone Drugs 0.000 description 1
229960004101 bemotrizinol Drugs 0.000 description 1
UNZOESWLBMZBEY-YHZPTAEISA-N bis(16-methylheptadecyl) (z)-but-2-enedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)\C=C/C(=O)OCCCCCCCCCCCCCCCC(C)C UNZOESWLBMZBEY-YHZPTAEISA-N 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000002826 coolant Substances 0.000 description 1
229920006037 cross link polymer Polymers 0.000 description 1
239000013078 crystal Substances 0.000 description 1
229940086555 cyclomethicone Drugs 0.000 description 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229940082337 dimethicone 20 Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229960004697 enzacamene Drugs 0.000 description 1
229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000004519 grease Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
229910000271 hectorite Inorganic materials 0.000 description 1
XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
239000011796 hollow space material Substances 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
239000003999 initiator Substances 0.000 description 1
239000001023 inorganic pigment Substances 0.000 description 1
XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
125000000468 ketone group Chemical group 0.000 description 1
230000003902 lesion Effects 0.000 description 1
239000012035 limiting reagent Substances 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000002932 luster Substances 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
229960003921 octisalate Drugs 0.000 description 1
FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
229960000601 octocrylene Drugs 0.000 description 1
WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
229940073665 octyldodecyl myristate Drugs 0.000 description 1
MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 description 1
239000002674 ointment Substances 0.000 description 1
239000012860 organic pigment Substances 0.000 description 1
DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
229960001173 oxybenzone Drugs 0.000 description 1
229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
229940057874 phenyl trimethicone Drugs 0.000 description 1
238000001126 phototherapy Methods 0.000 description 1
208000024335 physical disease Diseases 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
239000003380 propellant Substances 0.000 description 1
230000004224 protection Effects 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
239000008213 purified water Substances 0.000 description 1
238000010526 radical polymerization reaction Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
238000001878 scanning electron micrograph Methods 0.000 description 1
210000001732 sebaceous gland Anatomy 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000035807 sensation Effects 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
230000036548 skin texture Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000037072 sun protection Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
229940008424 tetradecamethylhexasiloxane Drugs 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
229960001295 tocopherol Drugs 0.000 description 1
229930003799 tocopherol Natural products 0.000 description 1
235000010384 tocopherol Nutrition 0.000 description 1
239000011732 tocopherol Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
230000002087 whitening effect Effects 0.000 description 1
239000011787 zinc oxide Substances 0.000 description 1
JRFBNCLFYLUNCE-UHFFFAOYSA-N zinc;oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Zn+2] JRFBNCLFYLUNCE-UHFFFAOYSA-N 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Birds (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Physics & Mathematics (AREA)
Geometry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Cosmetics (AREA)

KR1020190057114A 2019-05-15 2019-05-15 개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물 KR20200132142A (ko)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
KR1020190057114A KR20200132142A (ko)	2019-05-15	2019-05-15	개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물
SG11202110332WA SG11202110332WA (en)	2019-05-15	2020-04-23	Uv-blocking cosmetic composition having improved sebum absorption ability
PCT/KR2020/005395 WO2020231036A1 (ko)	2019-05-15	2020-04-23	개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물
TW109114991A TW202108116A (zh)	2019-05-15	2020-05-06	具有皮脂吸收能力之防曬用化妝品組成物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR1020190057114A KR20200132142A (ko)	2019-05-15	2019-05-15	개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물

Publications (1)

Publication Number	Publication Date
KR20200132142A true KR20200132142A (ko)	2020-11-25

Family

ID=73290239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020190057114A KR20200132142A (ko)	2019-05-15	2019-05-15	개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물

Country Status (4)

Country	Link
KR (1)	KR20200132142A (zh)
SG (1)	SG11202110332WA (zh)
TW (1)	TW202108116A (zh)
WO (1)	WO2020231036A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2023054803A1 (ko) *	2021-09-29	2023-04-06	코스맥스 주식회사	고분자 파우더를 포함하는 유분산 고형 화장료 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101543019B1 (ko)	2008-11-07	2015-08-10	(주)아모레퍼시픽	금속수산화물을 함유하는 피지 제거용 화장료 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2867676B1 (fr) *	2004-03-22	2006-06-02	Oreal	Composition cosmetique comprenant des particules concaves
FR2902648B1 (fr) *	2006-06-22	2018-05-18	L'oreal	Composition photoprotectrice aqueuse contenant des particules concaves ou annulaires de materiau silicone et au moins un filtre uv
KR101833612B1 (ko) *	2016-03-30	2018-02-28	선진뷰티사이언스(주)	다량의 유기계 자외선 차단제를 함유하는 고분자 복합입자 및 그의 제조방법
KR20180063664A (ko) *	2016-12-02	2018-06-12	코오롱생명과학 주식회사	자외선 차단용 화합물이 담지된 반구형의 고분자 비드, 이의 제조방법 및 이를 포함하는 자외선 차단용 조성물
KR102587916B1 (ko) *	2017-11-16	2023-10-11	(주)아모레퍼시픽	유기계 자외선 차단제를 포함하는 실리콘중수 타입의 화장료 조성물

2019
- 2019-05-15 KR KR1020190057114A patent/KR20200132142A/ko not_active Application Discontinuation
2020
- 2020-04-23 WO PCT/KR2020/005395 patent/WO2020231036A1/ko active Application Filing
- 2020-04-23 SG SG11202110332WA patent/SG11202110332WA/en unknown
- 2020-05-06 TW TW109114991A patent/TW202108116A/zh unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101543019B1 (ko)	2008-11-07	2015-08-10	(주)아모레퍼시픽	금속수산화물을 함유하는 피지 제거용 화장료 조성물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2023054803A1 (ko) *	2021-09-29	2023-04-06	코스맥스 주식회사	고분자 파우더를 포함하는 유분산 고형 화장료 조성물

Also Published As

Publication number	Publication date
WO2020231036A1 (ko)	2020-11-19
SG11202110332WA (en)	2021-12-30
TW202108116A (zh)	2021-03-01

Legal Events

Date	Code	Title
2021-11-29	A201	Request for examination
2023-10-17	E902	Notification of reason for refusal
2024-06-21	E902	Notification of reason for refusal

Publication	Publication Date	Title
JPWO2013132914A1 (ja)	2015-07-30	日焼け止め用組成物
WO1997044008A1 (en)	1997-11-27	Topical barrier composition containing silicone and bentonite
KR102587335B1 (ko)	2023-10-12	유기 자외선 차단제 프리 자외선 차단용 화장료 조성물
CA2292669A1 (en)	1998-12-10	Wet appliable sunscreen and makeup and method for testing sunscreens for efficacy
KR20110001539A (ko)	2011-01-06	유기자외선 차단제가 담지된 중공성 구형 실리카 복합안료의 제조방법 및 이를 함유한 자외선 차단용 화장료 조성물
CN110248639A (zh)	2019-09-17	个人护理组合物
JP3614511B2 (ja)	2005-01-26	日焼け止め用水中油型乳化化粧料
KR20200132142A (ko)	2020-11-25	개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물
JP6985910B2 (ja)	2021-12-22	油中水型乳化化粧料
KR102360819B1 (ko)	2022-02-09	유화 분리 방지 화장료 조성물, 이를 함침시킨 담체 및 이를 포함하는 화장품
KR100845731B1 (ko)	2008-07-11	미백 활성물질을 함유하는 분말형 화장료 조성물
JPH09263523A (ja)	1997-10-07	日焼け止め化粧料
TWI791673B (zh)	2023-02-11	包含有機uv吸收劑的水矽型態化妝品組成物
JP3665800B2 (ja)	2005-06-29	ゲル状メーキャップ化粧料
JP3634977B2 (ja)	2005-03-30	油性化粧料
KR101542917B1 (ko)	2015-08-07	수불용성 스폰지에 자외선 차단기능을 지닌 화장료 조성물이 함침된 화장품
JP2002265333A (ja)	2002-09-18	肌の凹凸隠し用油性化粧料
KR20200132710A (ko)	2020-11-25	비스-에틸헥실옥시페놀 메톡시페닐 트리아진 복합 제형을 포함하는 자외선 차단용 조성물
JPH05238924A (ja)	1993-09-17	日焼け防止化粧料
JP2002265342A (ja)	2002-09-18	紫外線防御化粧料
KR102174588B1 (ko)	2020-11-06	유해광선 차단용 유중수형 화장료 조성물
KR101198017B1 (ko)	2012-11-06	대마섬유를 포함하는 자외선 차단 및/또는 지성피부 조절용 조성물
WO2020231163A1 (ko)	2020-11-19	비스-에틸헥실옥시페놀 메톡시페닐 트리아진 복합 제형을 포함하는 자외선 차단용 조성물
TW201936166A (zh)	2019-09-16	防曬化妝料
JP2004137226A (ja)	2004-05-13	化粧料

KR20200132142A - 개선된 피지 흡유능을 갖는 자외선 차단용 화장료 조성물 - Google Patents

Info

Links

Images

Classifications

Landscapes

Priority Applications (4)

Applications Claiming Priority (1)

Publications (1)

Family

ID=73290239

Family Applications (1)

Country Status (4)

Cited By (1)

Citations (1)

Family Cites Families (5)

Patent Citations (1)

Cited By (1)

Also Published As

Similar Documents

Legal Events